Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jia Jie Biomedical Co., Ltd. (4109.TWO)
Kaohsiung, TW
Jia Jie Biomedical Co., Ltd., headquartered in Kaohsiung, Taiwan, was established in 1995. Formerly known as Murad Chia Jei Biotechnology Co., Ltd. until its rebranding in June 2019, the company primarily specializes in the production and distribution of health foods and wellness products across both Taiwan and Mainland China. The company's core operations encompass the processing, sale, and trade of softshell turtle-derived food items, as well as the manufacturing of dairy products. Its diversified food portfolio also features a range of specialty items such as softshell turtle egg powder capsules, enzyme powders, tortoise jelly, softshell turtle oil, and various other encapsulated nutritional supplements. Beyond its food production, Jia Jie Biomedical engages in comprehensive import/export activities, product distribution, and managing bidding and quotation procedures for its offerings. It also operates as a wholesaler for a broad array of consumer goods, including non-alcoholic beverages, confectioneries, baked goods, dietary supplements, general groceries, everyday household items, and cosmetics. Further expanding its business scope, the company manufactures water purification systems and their associated components, provides brokerage services for life and property insurance, and invests in the research, development, and production of advanced aquatic product technologies and various biological solutions.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.45% | -2.61% | -3.86% | -19.42% | -29.11% | -27.74% | -33.33% | -22.22% | -20.62% | -50.83% | -15.02% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%-9.6% Q1'26: +1.7% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%-79.3% Q1'26: +25.0% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%-2.6% Q1'26: +5.3% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+0.2% Q1'26: +2.0% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+0.1% Q1'26: +0.8% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%+20.1% Q1'26: +6.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×74.59× ★ Q1'26: 2.27× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 2/5 | 4/5 |
| 2026-05-28 | B | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 2/5 | 4/5 |
| 2026-05-27 | B | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 2/5 | 4/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 2/5 | 4/5 |
| 2026-05-25 | B | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 2/5 | 4/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-21 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-05 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-04 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ming-Chuan Tseng | President | — | — |
| Qinghong Lin | Vice President of Finance Department & Accounting supervisor | — | — |
| Wen-Fang Hsieh | Chief Executive Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4109.TWO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
